NADPH protects against kainic acid-induced excitotoxicity via autophagy-lysosome pathway in rat striatum and primary cortical neurons

Toxicology. 2020 Apr 15:435:152408. doi: 10.1016/j.tox.2020.152408. Epub 2020 Feb 11.

Abstract

Purpose: To investigate the effects and mechanisms of NADPH on Kainic acid (KA)-induced excitotoxicity.

Methods: KA, a non-N-methyl-d-aspartate glutamate receptor agonist, was exposed to adult SD rats via intrastriatal injection and rat primary cortical neurons to establish excitotoxic models in vivo and in vitro, respectively. To determine the effects of NADPH on KA-induced excitotoxicity, neuronal survival, neurologically behavioral score and oxidative stress were evaluated. To explore the mechanisms of neuroprotective effects of NADPH, the autophagy-lysosome pathway related proteins were detected.

Results: In vivo, NADPH (1 mg/kg or 2 mg/kg) diminished KA (2.5 nmol)-induced enlargement of lesion size in striatum, improved KA-induced dyskinesia and reversed KA-induced activation of glial cells. Nevertheless, the neuroprotective effect of NADPH was not significant under the condition of autophagy activation. NADPH (2 mg/kg) inhibited KA (2.5 nmol)-induced down-regulation of TP-53 induced glycolysis and apoptosis regulator (TIGAR) and p62, and up-regulation of the protein levels of LC3-II/LC3-I, Beclin-1 and Atg5. In vitro, the excitotoxic neuronal injury was induced after KA (50 μM, 100 μM or 200 μM) treatment as demonstrated by decreased cell viability. Moreover, KA (100 μM) increased the intracellular levels of calcium and reactive oxygen species (ROS) and declined the levels of the reduced form of glutathione (GSH). Pretreatment of NADPH (10 μM) effectively reversed these changes. Meanwhile NADPH (10 μM) inhibited KA (100 μM)-induced down-regulation of TIGAR and p62, and up-regulation of the ratio of LC3-II/LC3-I, Beclin-1, Atg5, active-cathepsin B and active-cathepsin D.

Conclusions: Our data provide a possible mechanism that NADPH ameliorates KA-induced excitotoxicity by blocking the autophagy-lysosome pathway and up-regulating TIGAR along with its antioxidant properties.

Keywords: Autophagy-lysosome pathway; Excitotoxicity; KA; NADPH; TIGAR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis Regulatory Proteins / metabolism
  • Autophagy / drug effects*
  • Autophagy-Related Protein 5 / metabolism
  • Beclin-1 / metabolism
  • Behavior, Animal / drug effects
  • Cells, Cultured
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / metabolism
  • Cerebral Cortex / pathology
  • Corpus Striatum / drug effects*
  • Corpus Striatum / metabolism
  • Corpus Striatum / pathology
  • Excitatory Amino Acid Agonists / toxicity*
  • Kainic Acid / toxicity*
  • Lysosomes / drug effects*
  • Lysosomes / metabolism
  • Lysosomes / pathology
  • Male
  • Microtubule-Associated Proteins / metabolism
  • Motor Activity / drug effects
  • NADP / pharmacology*
  • Neurons / drug effects*
  • Neurons / metabolism
  • Neurons / pathology
  • Neuroprotective Agents / pharmacology*
  • Oxidative Stress / drug effects
  • Phosphoric Monoester Hydrolases / metabolism
  • Rats, Sprague-Dawley
  • Sequestosome-1 Protein / metabolism

Substances

  • Apoptosis Regulatory Proteins
  • Atg5 protein, rat
  • Autophagy-Related Protein 5
  • Beclin-1
  • Becn1 protein, rat
  • Excitatory Amino Acid Agonists
  • LC3 protein, rat
  • Microtubule-Associated Proteins
  • Neuroprotective Agents
  • Sequestosome-1 Protein
  • Sqstm1 protein, rat
  • NADP
  • Phosphoric Monoester Hydrolases
  • Tigar protein, rat
  • Kainic Acid